본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer 이영주
(표적치료연구과)
이영주:최유라:김선신, 박석연, 한지연1, Eun Hye Kang. Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer BRITISH JOURNAL OF CANCER. 2023-04-14; 2023; 128(12):2186~2196. IF 8.8 (2022)
최유라
(표적치료연구과)
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study Cheol-Young Park, Sang Woo Oh
Cheol-Young Park, Sang Woo Oh:이근석, Dong-Hoe Koo, Cheol-Young Park, Sang Woo Oh:심성훈, 채희정, 이은경3, 한재홍, 정소연, 이시연, 강한성, 이은숙. Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study BREAST CANCER-TARGETS AND THERAPY. 2023-04-14; 2023; 15:251~261. IF 2.6 (2022)
이근석
(혈액종양내과분과)
Hemodynamic Wall Shear Stress Measurements Using Ultrasound Feature Tracking Algorithm 박대우
(융합진단치료기술연구과)
박대우:박동찬:장준근. Hemodynamic Wall Shear Stress Measurements Using Ultrasound Feature Tracking Algorithm JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY. 2023-04-14; 2023; 18:3111~3116. IF 1.9 (2022)
박동찬
(융합진단치료기술연구과)
Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis 류준선
(이비인후과)
류준선, Seung Joon Baek:Yukyung Hong:유창환, 정유석, 석준걸, Ilju Kim, Hyunjin Moon, Jaehak Lee, Pattawika Lertpatipanpong. Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis ONCOGENE. 2023-04-13; 2023; 42(22):1832~1842. IF 8 (2022)
Yukyung Hong
[grant 수정 필요]Stomach tissue classification using autofluorescence spectroscopy and machine learning Jeon Woong Kang, Hyung Min Kim
Jeon Woong Kang, Hyung Min Kim:윤홍만, Soo Yeong Lim:국명철. [grant 수정 필요]Stomach tissue classification using autofluorescence spectroscopy and machine learning SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2023-04-13; 2023; 37(8):5825~5835. IF 3.1 (2022)
윤홍만
(종양외과학연구과)
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial Jae-Ho Cheong, Heike I. Grabsch
Jae-Ho Cheong, Heike I. Grabsch :김영우, Drolaiz H. W. Liu:국명철, Nina Sefcovicova, Jon P. Laye, Lindsay C. Hewitt, Andrew F. Irvine, Vincent Vromen, Yannick Janssen, Naser Davarzani, Gregorio E. Fazzi, Shahab Jolani, Veerle Melotte, Derek R. Magee, Hyunki Kim, Rupert Langer,. Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial BRITISH JOURNAL OF CANCER. 2023-04-07; 2023; 128(12):2318~2325. IF 8.8 (2022)
김영우
(암관리학과)
Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment 김윤희
(분자영상연구과)
김윤희, Kyun Heo:최선일:이유선, 이율민, 김현정, 임지은, 이미림, 김준기, 전아라, 우상명, 김인후. Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment JOURNAL OF CONTROLLED RELEASE. 2023-04-06; 2023; Online:Published. IF 10.8 (2022)
최선일
(융합기술연구부)
Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea 최귀선
(암관리학과)
최귀선:Xuan Quy Luu:이경민, 전재관, 서민아, 정규원, 최일주. Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea GASTRIC CANCER. 2023-04-05; 2023; 26:580~589. IF 7.4 (2022)
Luu Xuan QUY
(암관리학과)
Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent 박미경
(암의생명과학과)
박미경, Chang Hoon Lee:Lu Yu:이호, 노승배. Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023-04-04; 2023; 24(7):6712~. IF 5.6 (2022)
Lu Yu
Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway 박미경
(암의생명과학과)
박미경, Chang Hoon Lee:Lu Yu:장지윤, 노승배, 이호. Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway BIOCHEMICAL PHARMACOLOGY. 2023-04-03; 2023; 212:115537~. IF 5.8 (2022)
Lu Yu